Home
>
National Drug Code (NDC)
>
Betaxolol
Betaxolol - 17478-705-25 - (Betaxolol Hydrochloride)
Drug Information of Betaxolol
| Product NDC: | 17478-705 |
| Proprietary Name: | Betaxolol |
| Non Proprietary Name: | Betaxolol Hydrochloride |
| Active Ingredient(s): | 5 mg/mL & nbsp; Betaxolol Hydrochloride |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Betaxolol
| Product NDC: | 17478-705 |
| Labeler Name: | Akorn, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075386 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030401 |
Package Information of Betaxolol
| Package NDC: | 17478-705-25 |
| Package Description: | 1 VIAL in 1 CARTON (17478-705-25) > 2.5 mL in 1 VIAL |
NDC Information of Betaxolol
| NDC Code | 17478-705-25 |
| Proprietary Name | Betaxolol |
| Package Description | 1 VIAL in 1 CARTON (17478-705-25) > 2.5 mL in 1 VIAL |
| Product NDC | 17478-705 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Betaxolol Hydrochloride |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20030401 |
| Marketing Category Name | ANDA |
| Labeler Name | Akorn, Inc. |
| Substance Name | BETAXOLOL HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
